Reasons for Hospitalization and In-Hospital Mortality in Adults With Dermatomyositis and Polymyositis.
Journal
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
ISSN: 1536-7355
Titre abrégé: J Clin Rheumatol
Pays: United States
ID NLM: 9518034
Informations de publication
Date de publication:
01 03 2022
01 03 2022
Historique:
pubmed:
16
7
2021
medline:
25
2
2022
entrez:
15
7
2021
Statut:
ppublish
Résumé
Dermatomyositis (DM) and polymyositis (PM) are systemic autoimmune diseases that have been associated with high in-hospital mortality (IHM). The aim of this study was to use the National Inpatient Sample (NIS), a large US population database, to determine the reasons for hospitalization and IHM in patients with DM and PM. We conducted a medical records review of adult DM/PM hospitalizations in 2016 and 2017 in acute care hospitals across the United States using the NIS. The reasons for IHM and reasons for hospitalization were divided into 19 broad categories based on their principal International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10) diagnosis. A total of 27,140 hospitalizations carried either a principal or secondary ICD-10 code for DM or PM. The main reasons for hospitalization were rheumatologic (22%, n = 6085), cardiovascular (15%, n = 3945), infectious (13%, n = 3515), respiratory (12%, n = 3170), and gastrointestinal, (8%, n = 2150). A total of 3.5% of all patients experienced IHM. Infectious (34%, n = 325), respiratory (23%, n = 215), and cardiovascular (15%, n = 140) diagnoses were the most common reasons for IHM. Sepsis ICD-10 A41.9 was the most frequent specific principal diagnosis for both hospitalizations and IHM. Our analysis demonstrated that in the NIS the most common reasons for hospitalization in patients with DM/PM were rheumatologic diagnoses. However, IHM in these patients was most frequently from infectious diagnoses, highlighting the need for increased attention to infectious complications in these patients.
Identifiants
pubmed: 34262001
doi: 10.1097/RHU.0000000000001754
pii: 00124743-202203000-00029
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e433-e439Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Airio A, Kautiainen H, Hakala M. Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol . 2006;25:234–239.
Marie I. Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep . 2012;14:275–285.
Schiopu E, Phillips K, MacDonald PM, et al. Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine. Arthritis Res Ther . 2012;14:R22.
Taborda AL, Azevedo P, Isenberg DA. Retrospective analysis of the outcome of patients with idiopathic inflammatory myopathy: a long-term follow-up study. Clin Exp Rheumatol . 2014;32:188–193.
Lee J, Yim JJ, Yang SC, et al. Outcome of patients with connective tissue disease requiring intensive care for respiratory failure. Rheumatol Int . 2012;32:3353–3358.
Sherer Y, Shepshelovich D, Shalev T, et al. Outcome of patients having dermatomyositis admitted to the intensive care unit. Clin Rheumatol . 2007;26:1851–1855.
Danieli MG, Gambini S, Pettinari L, et al. Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study. Autoimmun Rev . 2014;13:1048–1054.
Wu C, Wang Q, He L, et al. Hospitalization mortality and associated risk factors in patients with polymyositis and dermatomyositis: a retrospective case-control study. PLoS One . 2018;13:e0192491.
Silva MA, Cogollo E, Isenberg DA. Why do patients with myositis die? A retrospective analysis of a single-centre cohort. Clin Exp Rheumatol . 2016;34:820–826.
Murray SG, Schmajuk G, Trupin L, et al. A population-based study of infection-related hospital mortality in patients with dermatomyositis/polymyositis. Arthritis Care Res (Hoboken) . 2015;67:673–680.
Zampieri S, Ghirardello A, Iaccarino L, et al. Polymyositis-dermatomyositis and infections. Autoimmunity . 2006;39:191–196.
Marie I, Ménard JF, Hachulla E, et al. Infectious complications in polymyositis and dermatomyositis: a series of 279 patients. Semin Arthritis Rheum . 2011;41:48–60.
Jacob H, Berkowitz D, McDonald E, et al. The esophageal motility disorder of polymyositis. A prospective study. Arch Intern Med . 1983;143:2262–2264. PMID: 6651419.
de Merieux P, Verity MA, Clements PJ, et al. Esophageal abnormalities and dysphagia in polymyositis and dermatomyositis. Arthritis Rheum . 1983;26:961–968.
Houser SM, Calabrese LH, Strome M. Dysphagia in patients with inclusion body myositis. Laryngoscope . 1998;108:1001–1005.
Badrising UA, Maat-Schieman ML, van Houwelingen JC, et al. Inclusion body myositis. Clinical features and clinical course of the disease in 64 patients. J Neurol . 2005;252:1448–1454.
Lynn SJ, Sawyers SM, Moller PW, et al. Adult-onset inflammatory myopathy: North Canterbury experience 1989–2001. Intern Med J . 2005;35:170–173.
Schwarz MI. Pulmonary and cardiac manifestations of polymyositis-dermatomyositis. J Thorac Imaging . 1992;7:46–54.
Fathi M, Lundberg IE, Tornling G. Pulmonary complications of polymyositis and dermatomyositis. Semin Respir Crit Care Med . 2007;28:451–458.
Ungprasert P, Cheungpasitporn W, Thongprayoon C, et al. Inpatient epidemiology of dermatomyositis and polymyositis in the United States [abstract]. Arthritis Rheumatol . 2019;71(suppl 10). Abstract 1278.
Huber AM, Mamyrova G, Lachenbruch PA, et al; Childhood Myositis Heterogeneity Collaborative Study Group. Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken) . 2014;66:732–740.
Limaye VS, Lester S, Blumbergs P, et al. Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus. Int J Rheum Dis . 2010;13:132–137.
Peng JM, Du B, Wang Q, et al. Dermatomyositis and polymyositis in the intensive care unit: a single-center retrospective cohort study of 102 patients. PLoS One . 2016;11:e0154441.